2005
DOI: 10.1177/1534735404273861
|View full text |Cite
|
Sign up to set email alerts
|

Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later

Abstract: The effect of ascorbic acid on cancer has been a subject of great controversy. This is a follow-up review of the 1979 article by Cameron, Pauling, and Leibovitz published in Cancer Research. In this updated version, the authors address general aspects of ascorbic acid and cancer that have been presented before, while reviewing, analyzing, and updating new existing literature on the subject. In addition, they present and discuss their own mechanistic hypothesis on the effect of ascorbic acid on the cancer cell.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
99
0
5

Year Published

2011
2011
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 113 publications
(107 citation statements)
references
References 110 publications
(163 reference statements)
2
99
0
5
Order By: Relevance
“…Intracellular ascorbate concentrations in the low millimolar range (much higher than that in plasma) seem to be necessary to support its role as an antioxidant [32] and as a cofactor for dioxygenase enzymes [33]. Whether vitamin C functions as an antioxidant or pro-oxidant is determined by at least three factors: 1) the redox-potential of the cellular environment; 2) the presence/absence of transition metals; and 3) the local concentrations of ascorbate [34][35][36]. The last factor is particularly relevant in treatments that depend on the antioxidant/ pro-oxidant property of vitamin C, because it can be readily manipulated and controlled in vivo to achieve desired effects [34].…”
Section: Vitamin C As An Antioxidantmentioning
confidence: 99%
“…Intracellular ascorbate concentrations in the low millimolar range (much higher than that in plasma) seem to be necessary to support its role as an antioxidant [32] and as a cofactor for dioxygenase enzymes [33]. Whether vitamin C functions as an antioxidant or pro-oxidant is determined by at least three factors: 1) the redox-potential of the cellular environment; 2) the presence/absence of transition metals; and 3) the local concentrations of ascorbate [34][35][36]. The last factor is particularly relevant in treatments that depend on the antioxidant/ pro-oxidant property of vitamin C, because it can be readily manipulated and controlled in vivo to achieve desired effects [34].…”
Section: Vitamin C As An Antioxidantmentioning
confidence: 99%
“…An antioxidative property may be defined as a capacity for the scavenging of free radicals including ROS and reactive nitrogen species by donating a hydrogen or an electron (35). There have been many reports of the therapeutic or preventive efficacy of vitamin C as an anticancer agent (36,37), but no study of the DENinduced HCC model has been conducted using congenital vitamin C-deficient Smp30 KO mice. In the present study, we promote the proliferation of surviving hepatocytes as a compensatory effect (39).…”
Section: Discussionmentioning
confidence: 99%
“…Vitamin C has previously been used as an unorthodox therapy for patients with cancer (14); however, in most clinical settings, vitamin C is used as an auxillary treatment and the dosage is low. Low-dose vitamin C (25-50 µg/ml) does not induce apoptosis; conversely, it is associated with stem cell proliferation and maintenance (4,8).…”
Section: Discussionmentioning
confidence: 99%